News Details

Market Commentary - Stock Alert

ICICI Bank, ICICI Securities, BPCL, Canara Bank in focus

30-Jun-23    08:42

ICICI Bank, ICICI Securities: ICICI Bank said the board members have approved the draft scheme of arrangement for delisting of equity shares of ICICI Securities. Pursuant to the Scheme, the public shareholders of ICICI Securities would be allotted 67 equity shares of ICICI Bank for every 100 shares held by them in ICICI Securities.

Power Grid Corporation of India: The power transmission company on Wednesday announced that its committee of directors on investment on projects has accorded investment approvals for three projects aggregating to Rs 388.94 crore.

IndusInd Bank: IndusInd Bank said that its board has appointed Vivek Bajpeyi as the chief risk officer of the bank with effect from 28 June 2023 till 30 September 2025.

Bharat Petroleum Corporation (BPCL): BPCL on Wednesday announced that its board has approved the proposal for raising capital up to Rs 18,000 crore through rights issue of equity shares.

Canara Bank: Canara Bank said that its board has approved the capital raising plan of the bank for the financial year 2023-24 amounting up to Rs 7,500 crore by way of debt instruments.

Aurobindo Pharma: Aurobindo Pharma said that its step-down wholly owned subsidiary, Auro PR, Puerto Rico is undertaking a restructuring of its facility to enhance production volume.

AU Small Finance Bank: The bank said that its board has approved to raise Rs 5,000 crore by issuing equity shares and Rs 6,000 crore by debt instruments.

Tata Communications: Tata Communications on Wednesday announced that it will acquire US-based and New York Stock Exchange-listed Kaleyra Inc for $100 million in an all-cash deal.

Krsnaa Diagnostics: Krsnaa Diagnostics said that it has received letter of acceptance from National Health Mission, Assam for establishment, operation and maintenance of laboratory diagnostic centres in Assam.

Zydus Lifesciences: The drug maker said that it has received tentative approval from the United States Food and Drug Administration (USFDA) for Palbociclib tablets. Palbociclib is used to treat a certain type of breast cancer.

Shaily Engineering Plastics: The company informed that Ashish Somani, chief financial officer (CFO) of the company has tendered his resignation on 28 June 2023, due to personal reasons.

Schaeffler India: Schaeffler India has announced the inauguration of manufacturing hall 2 at its manufacturing facility at Savli, Vadodara Gujarat.

Sanghi Industries: The company has resumed its operations of cement plant located at Sanghipuram, Kutch in Gujarat.

Powered by Capital Market - Live News